Systems and methods for treating aneurysms

US12569252B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12569252-B2
Application numberUS-202318505645-A
CountryUS
Kind codeB2
Filing dateNov 9, 2023
Priority dateNov 4, 2019
Publication dateMar 10, 2026
Grant dateMar 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Treatment of aneurysms can be improved by delivering an occlusive member (e.g., an expandable braid) to an aneurysm sac in conjunction with an embolic element (e.g., coils, embolic material). A treatment system for such treatment can include an electrolytically corrodible core wire having a proximal portion, a distal portion, and a detachment zone between the proximal portion and the distal portion. An occlusive member having a proximal hub is coupled to the core wire distal portion. A conduit extends along at least a portion of the core wire. The conduit has a lumen configured to pass an embolic element therethrough.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A treatment system comprising: an electrolytically corrodible core member having a proximal portion, a distal portion, and a detachment zone between the proximal portion and the distal portion; an occlusive member having a proximal hub coupled to the core member distal portion, the occlusive member having: (1) a constrained state for delivery to an aneurysm; (2) a first expanded state in which at least a portion of the occlusive member is configured to be disposed across a neck of the aneurysm, and (3) a second expanded state in which an embolic element disposed between a distal face of the occlusive member and a wall of the aneurysm causes a sidewall of a portion of the occlusive member to invert such that the portion of the occlusive member is convex towards the aneurysm wall in the first expanded state and concave towards the aneurysm wall in the second expanded state; and a conduit extending along at least a portion of the core member, the conduit having a distal portion configured to be disposed within the aneurysm along with the occlusive member, the conduit having a lumen configured to pass the embolic element therethrough. 2 . The treatment system of claim 1 , wherein the conduit comprises a flexible tubular member. 3 . The treatment system of claim 1 , wherein the conduit comprises a hypotube. 4 . The treatment system of claim 1 , wherein the core member comprises an elongated tubular member. 5 . The treatment system of claim 1 , wherein the conduit distal end extends to or distal to a distal end of the occlusive member. 6 . The treatment system of claim 1 , wherein the core member comprises a proximal insulating layer annularly contacting the proximal portion of the core member and a distal insulating layer annularly contacting the distal portion of the core member. 7 . The treatment system of claim 1 , wherein the embolic element is a liquid embolic. 8 . A treatment system comprising: a core member having a proximal portion, a distal portion, and a detachment zone between the proximal portion and the distal portion; an occlusive member having a proximal hub coupled to the core member distal portion, the occlusive member having a constrained state for delivery to an aneurysm and an expanded state in which at least a portion of the occlusive member is configured to be disposed across a neck of the aneurysm while an embolic element is disposed between a distal face of the occlusive member and a wall of the aneurysm, wherein the occlusive member has a first internal volume in the expanded state in which a portion of the occlusive member is convex towards a wall of the aneurysm and the occlusive member is configured to at least partially collapse when contacted by the embolic element, thereby reducing the internal volume from the first internal volume to a second internal volume in which the portion of the occlusive member is concave towards the aneurysm wall; and a conduit lumen extending along at least a portion of the core member and configured to pass the embolic element therethrough to within the aneurysm, the conduit lumen having a distal end configured to be disposed within the aneurysm concurrently with the occlusive member. 9 . The treatment system of claim 8 , wherein the conduit lumen is defined by a conduit extending alongside at least a portion of the core member, the conduit having a distal end configured to extend distal to a distal end of the occlusive member. 10 . The treatment system of claim 8 , wherein the detachment zone comprises a portion of the core member configured to be severed via electrolytic corrosion. 11 . The treatment system of claim 8 , wherein the core member comprises an elongate tubular shaft. 12 . The treatment system of claim 11 , wherein the conduit lumen extends through the elongate tubular shaft. 13 . The treatment system of claim 8 , wherein the conduit lumen is configured to pass the embolic element through the core member. 14 . The treatment system of claim 8 , wherein the embolic element is a liquid embolic. 15 . A treatment system comprising: an elongate tubular member having a proximal portion, a distal portion, and a detachment zone between the proximal portion and the distal portion; an occlusive member having a proximal hub coupled to the tubular member distal portion, the occlusive member having a constrained state for delivery to an aneurysm and an expanded state in which at least a portion of the occlusive member is configured to be disposed across a neck of the aneurysm while an embolic element is disposed between a distal face of the occlusive member and a wall of the aneurysm, wherein the occlusive member has a first internal volume in the expanded state in which a portion of the occlusive member is convex towards a wall of the aneurysm and the occlusive member is configured to at least partially collapse when contacted by the embolic element, thereby reducing the internal volume from the first internal volume to a second internal volume in which the portion of the occlusive member is concave towards the aneurysm wall; and a conduit extending through the elongate tubular member and defining a conduit lumen configured to pass the embolic element therethrough to within the aneurysm, the conduit lumen having a distal end configured to be in fluid communication with the aneurysm while the occlusive member is disposed within the aneurysm. 16 . The treatment system of claim 15 , wherein the detachment zone comprises a portion of the tubular member configured to be severed via electrolytic corrosion. 17 . The treatment system of claim 15 , wherein the conduit comprises a flexible tubular member. 18 . The treatment system of claim 15 , wherein the conduit comprises a hypotube. 19 . The treatment system of claim 15 , wherein the conduit distal end extends to a distal end of the occlusive member. 20 . The treatment system of claim 15 , wherein the embolic element is a liquid embolic.

Assignees

Inventors

Classifications

  • Radiopaque markers visible in an X-ray image · CPC title

  • using X-rays, e.g. fluoroscopy · CPC title

  • having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526) · CPC title

  • elastic or resilient · CPC title

  • inflatable (A61B2017/22051 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12569252B2 cover?
Treatment of aneurysms can be improved by delivering an occlusive member (e.g., an expandable braid) to an aneurysm sac in conjunction with an embolic element (e.g., coils, embolic material). A treatment system for such treatment can include an electrolytically corrodible core wire having a proximal portion, a distal portion, and a detachment zone between the proximal portion and the distal por…
Who is the assignee on this patent?
Covidien Lp
What technology area does this patent fall under?
Primary CPC classification A61B17/12031. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).